ABOUT THIS EPISODE
- mRNA research before COVID and how "mRNA is code" [3:21]
- The early days of COVID: designing a vaccine in 48 hours [5:44]
- The software behind the vaccine: getting mRNA researchers out of Excel and into a drug design studio [9:11]
- The first draft of the vaccine was the final draft [11:10]
- How the government sped up vaccine development for COVID [12:18]
- What other new vaccines will come from mRNA? [15:34]
- How far are we from these mRNA vaccines? What do we need for them to be widely available? [25:31]
- Open sourcing Moderna [27:53]
- When will COVID vaccines be available for a five year old? [29:47]
- The three factors that matter when dealing with COVID variants [30:46]
- How might open source shake up biotech [36:41]
- The moonshot applications for mRNA therapeutics [39:43]
- Advice for building a new category in a regulated environment [46:49]
- The clinical or regulatory advances needed to speed drug time to market [51:08]
- Challenge trials for vaccines: good or bad idea? [59:11]
It's Time to Heal, Mondays at 5pm PT on Clubhouse. Join the a16z bio team — Jorge Conde, Vineeta Agarwala, Julie Yoo, and Vijay Pande — plus special guests as they explore all the ways that biology is technology.
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Finding and backing companies that can reach escape velocity is the name of the game over here at a16z Growth—but picking those winners is far from easy. David George, head of the a16z Growth fund, sat down with the I/O podcast to discuss his mental models for growth-stage investing, what it really…
High-performance compute is the bedrock of generative AI, and if there’s anyone who knows about high-performance chips, it’s AMD CEO Lisa Su. In this wide-ranging conversation with a16z Operating Partner Bob Swan—himself formerly CEO of Intel—Lisa lays out her vision for the evolution of compute wi…
In this episode, a16z Partner Seema Amble chats with Tomer London, co-founder of Gusto, about establishing product-market fit and product discovery. London shares how Gusto, now valued at ~$10 billion with 300,000+ customers, identified early customers who could provide valuable feedback that helpe…
In this conversation with a16z general partner David George, Scale AI founder and CEO Alexandr Wang discusses the three pillars of AI—models, compute, and data—and how creating abundant data is core to the evolution of gen AI. With Scale’s work across enterprise, automotive, and the public sector, …
a16z general partner David Haber talks to John Stecher, Chief Technology Officer at Blackstone, where he advances cutting-edge technology, heads up innovation investing, and advises the firm’s investment teams and portfolio companies. The conversation covers how he decides whether to build tech in-…
Disclaimer: The podcast and artwork embedded on this page are from Andreessen Horowitz, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
